CHARLES SCHWAB INVESTMENT MANAGEMENT INC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 43 filers reported holding LEAP THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10,880
-24.4%
32,0000.0%0.00%
Q4 2022$14,400
-50.3%
32,0000.0%0.00%
Q3 2022$29,000
-21.6%
32,0000.0%0.00%
Q2 2022$37,000
-33.9%
32,0000.0%0.00%
Q1 2022$56,000
-46.2%
32,0000.0%0.00%
Q4 2021$104,000
+188.9%
32,000
+70.8%
0.00%
Q1 2021$36,000
-57.6%
18,733
-49.9%
0.00%
Q4 2020$85,000
+13.3%
37,4240.0%0.00%
Q3 2020$75,00037,4240.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders